In this video, Tom Lowe, director of Physicians Awareness UBI, and Kenneth J. Dillon, author of Healing Photons, discuss the history, science, challenges, and promise of Biophotonic Therapy. Also known as ultraviolet blood irradiation, BT treats small amounts of blood with light in extracorporeal or intravenous modes. BT was invented by Emmet Knott in the 1920s. Hundreds of clinical studies have shown its effectiveness in various indications, e.g., against childhood asthma. Thousands of practitioners around the world use it to treat a wide range of disorders. BT is the leading phototherapeutic treatment of infectious diseases.
[For a fuller discussion of Biophotonic Therapy and the underlying science, including citations to the medical literature, see Healing Photons: The Science and Art of Blood Irradiation Therapy. For a brief discussion, see 10 Key Points about Biophotonic Therapy. See also the video Rethinking Biophotonic Therapy.]
Overview
Biophotonic Therapy uses light in an extracorporeal or intravenous mode to activate the red blood cells, a form of immunity inherited from humankind’s distant oligocellular ancestors. BT has an instructive 80-year history (see below); a range of modalities; well-characterized mechanisms of action; a wide array of indications; several counterindications; well-understood, limited side-effects in certain cases; and a scientific literature that now includes some 400 articles as well as a dozen books. No drug resistance to BT has ever been reported.